Mirabiologics
Tokyo, JP · 1 known investors
MiraBiologics is a Japanese biopharmaceutical drug discovery company that uses its LassoGraft Technology to graft cyclic peptides onto scaffold proteins for the development of novel biologics. It pursues collaborative R&D partnerships to create innovative biopharmaceuticals.
Founders & leadership
HS
Hiroaki SugaCo-founder; Professor, University of Tokyo
JT
Junichi TakagiCo-founder; Director & Professor, Osaka University
MK
Masuhiro KatoRepresentative Director & President
I
IgarashiChief Operating Officer
Investors · 1
Frequently asked questions
- What does Mirabiologics do?
- MiraBiologics is a Japanese biopharmaceutical drug discovery company that uses its LassoGraft Technology to graft cyclic peptides onto scaffold proteins for the development of novel biologics. It pursues collaborative R&D partnerships to create innovative biopharmaceuticals.
- Who founded Mirabiologics?
- Mirabiologics was founded by Hiroaki Suga, Junichi Takagi.
- Who are Mirabiologics's investors?
- Mirabiologics's investors include Shinsei Capital Partners.
- Where is Mirabiologics headquartered?
- Mirabiologics is headquartered in Tokyo, JP.